Hyperbaric chamber therapy, medically known as hyperbaric oxygen therapy (HBOT), is a treatment modality that involves breathing near‑pure oxygen in a pressurized chamber . By increasing the atmospheric pressure to levels higher than normal (typically 2 to 3 times greater), the therapy enables the lungs to gather significantly more oxygen than would be possible under ordinary conditions . This oxygen‑rich plasma is then circulated throughout the body, reaching tissues that are hypoxic or ischemic, thereby promoting healing, reducing edema, and modulating immune responses.
The origins of hyperbaric medicine date back to 1662, when a British physician constructed the first pressurized airtight chamber, long before oxygen itself was discovered . Modern HBOT is grounded in well‑established gas laws. Boyle's Law explains that increasing ambient pressure reduces the volume of gas bubbles—a principle crucial for treating decompression sickness . Henry's Law states that the amount of gas dissolved in a liquid is proportional to its partial pressure; under hyperbaric conditions, the partial pressure of oxygen in the plasma can exceed 20 times that of breathing room air at sea level . For example, at 3 atmospheres absolute (ATA) breathing 100% oxygen, the oxygen content in whole blood increases by about 42%, almost entirely from oxygen dissolved in the plasma .
• Enhanced Oxygen Delivery: The dramatic increase in plasma oxygen provides sufficient supply to drive cellular respiration, even in the presence of severe anemia or compromised circulation .
• Vasoconstriction with Improved Oxygenation: Hyperoxia reduces local nitric oxide production, leading to vasoconstriction and decreased tissue edema—particularly beneficial in acute brain injury and compartment syndrome—while still delivering more oxygen to the tissues because of the hyperoxic state .
• Angiogenesis and Wound Healing: HBOT upregulates key growth factors such as vascular endothelial growth factor (VEGF), platelet‑derived growth factor (PDGF), and fibroblast growth factor (FGF) . These stimulate capillary budding, granulation tissue formation, and collagen synthesis, ultimately promoting the growth of new blood vessels and connective tissue .
• Antimicrobial Effects: Neutrophils and macrophages consume large amounts of oxygen to produce reactive oxygen species (e.g., hydrogen peroxide, superoxide) that kill bacteria . By hyperoxygenating tissues, HBOT enhances the immune system's ability to fight infections, especially in hypoxic wound beds .
• Bubble Reduction: Increased pressure physically compresses gas bubbles (decompression sickness, arterial gas embolism) according to Boyle's Law, while high oxygen concentrations displace nitrogen from the bubbles, dissolving them away .
HBOT is approved by the Undersea and Hyperbaric Medical Society (UHMS) for 15 specific indications, which can be grouped into emergency conditions, wound healing, and antimicrobial applications . Its therapeutic value is recognized across multiple medical specialties.
• Decompression Sickness and Arterial Gas Embolism: Classic diving injuries where gas bubbles form in tissues or blood vessels. HBOT reduces bubble size, improves circulation, and reverses local hypoxia . Early treatment is associated with better outcomes, but therapy can still be beneficial even days after symptom onset .
• Carbon Monoxide Poisoning: Carbon monoxide binds hemoglobin with more than 200 times the affinity of oxygen. HBOT accelerates the dissociation of carboxyhemoglobin, reducing its half‑life from 4‑6 hours on room air to just 23 minutes at 3 ATA .
• Acute Traumatic Ischemia and Crush Injuries: By increasing oxygen delivery to compromised tissues and reducing edema, HBOT can help salvage limbs and prevent tissue death .
• Gas Gangrene (Clostridial Myonecrosis): High oxygen tensions inhibit the growth of anaerobic bacteria and toxin production, making HBOT a critical adjunct to surgery and antibiotics .
• Diabetic Lower Extremity Wounds: For Wagner grade III or higher wounds that have not responded to 30 days of standard care, HBOT is considered medically necessary . It stimulates angiogenesis, fights infection, and enhances granulation, often preventing amputation .
• Chronic Non‑Healing Wounds: Including arterial insufficiency ulcers, pressure ulcers, and venous stasis ulcers in selected patients with hypoxia or compromised grafts .
• Compromised Skin Grafts and Flaps: HBOT supports the survival of surgical flaps and grafts at risk of ischemic failure by improving oxygenation and neovascularization .
• Acute Thermal Burns: Deep second‑degree and third‑degree burns benefit from enhanced healing and infection control .
• Osteoradionecrosis (ORN) and Soft Tissue Radiation Necrosis: Delayed radiation injury creates hypoxic, hypocellular tissue prone to breakdown. HBOT promotes angiogenesis and fibroblast proliferation, aiding healing in irradiated jaws, pelvic tissues, and other sites .
• Radiation Cystitis and Proctitis: Used to manage bleeding and tissue damage following pelvic radiation .
• Prophylaxis Before Dental Surgery in Radiated Jaws: Pre‑ and post‑operative HBOT reduces the risk of ORN following tooth extraction or dental implant placement in previously irradiated bone.
• Idiopathic Sudden Sensorineural Hearing Loss (ISSHL): Approved for individuals with hearing loss of at least 70 decibels who have not responded adequately to glucocorticoid treatment .
• Central Retinal Artery Occlusion (CRAO): Sudden vision loss from blocked retinal blood flow may be treated with HBOT to restore oxygenation to retinal tissue.
• Intracranial Abscess: HBOT serves as an adjunct to antibiotics and surgical drainage by enhancing oxygen penetration and immune function.
• Severe Anemia When Transfusion Is Impossible or Delayed: The massive increase in plasma oxygen can sustain vital organ function temporarily in patients with exceptional blood loss who cannot receive transfusions.
• Necrotizing Soft Tissue Infections: Including necrotizing fasciitis, where HBOT helps control infection spread and supports tissue salvage.
